FindMyRecallSubscribe
Class I: serious health riskTerminated

Fagron Compounding Services LLC dba Fagron Sterile Services Neostigmine Methylsulfate Injection Solution Recall

Neostigmine Methylsulfate Injection Solution, 5 mg per 5 mL, 1 mg per mL, 5 mL prefille…

Fagron Compounding Services LLC dba Fagron Sterile Services · Wichita, KS

Risk level
Class I
Reported by FDA
Jul 11, 2018
Recall ID
D-0910-2018
Check your lot numberHow we source this data

Summary

Fagron Compounding Services LLC dba Fagron Sterile Services recalled Neostigmine Methylsulfate Injection Solution starting Jun 29, 2018. The FDA classified it as Class I (serious health risk) and published enforcement report D-0910-2018 on Jul 11, 2018. Reason: Labeling: Label Error on Declared Strength: syringes of Neostigmine Methylsulfate 1 mg per mL, 5 mg per 5 mL may be incorrectly labeled as Neostigmine Methylsulfate 1 mg per mL, 3 mg per 3 mL. Status: Terminated.

Why it was recalled

Labeling: Label Error on Declared Strength: syringes of Neostigmine Methylsulfate 1 mg per mL, 5 mg per 5 mL may be incorrectly labeled as Neostigmine Methylsulfate 1 mg per mL, 3 mg per 3 mL.

Product description

Neostigmine Methylsulfate Injection Solution, 5 mg per 5 mL, 1 mg per mL, 5 mL prefilled syringe, 5 syringes per package, Rx only, Fagron Sterile Services, ICB Laboratories, 8710 E 34th St. N., Wichita, KS 67205, NDC 71266-2003-02.

Lot numbers, UPCs & expiration codes

Lot #: C274-000004690, BUD: 09/21/18.

Where it was sold

Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0910-2018
Classification
Class I
Status
Terminated
Recall initiated
Jun 29, 2018
FDA report date
Jul 11, 2018
Quantity
840 prefilled syringes
Recall type
Voluntary: Firm initiated
Recalling firm
Fagron Compounding Services LLC dba Fagron Sterile Services

Original FDA data

Every field from FDA enforcement report D-0910-2018, exactly as published.

Show all FDA fields
City
Wichita
State
KS
Status
Terminated
Country
United States
Event ID
80383
Address
8710 E 34th St N
Code information
Lot #: C274-000004690, BUD: 09/21/18.
Postal code
67226-2636
Report date
Jul 11, 2018
Product type
Drugs
Recall number
D-0910-2018
Classification
Class I
Recalling firm
Fagron Compounding Services LLC dba Fagron Sterile Services
Product quantity
840 prefilled syringes
Termination date
Aug 31, 2020
Reason for recall
Labeling: Label Error on Declared Strength: syringes of Neostigmine Methylsulfate 1 mg per mL, 5 mg per 5 mL may be incorrectly labeled as Neostigmine Methylsulfate 1 mg per mL, 3 mg per 3 mL.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Neostigmine Methylsulfate Injection Solution, 5 mg per 5 mL, 1 mg per mL, 5 mL prefilled syringe, 5 syringes per package, Rx only, Fagron Sterile Services, ICB Laboratories, 8710 E 34th St. N., Wichita, KS 67205, NDC 71266-2003-02.
Distribution pattern
Nationwide in the USA
Recall initiation date
Jun 29, 2018
Center classification date
Jul 6, 2018

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0910-2018, published Jul 11, 2018. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls